level	trait	total_gwas_snps	trait_snps	eqtls_in_catalog	trait_eqtls	pval	adj_pval	sim_count	sim_pval
level0	White matter microstructure (mean diusivities)	344506	198	1138	8	4.0396477603407787e-07	0.0003882101497687	1	0.004
level0	White matter microstructure (radial diusivities)	344506	250	1138	9	2.0281747416416934e-07	0.0001949075926717	0	0.002
level0	Hemoglobin concentration	344506	1081	1138	21	2.0453812372537224e-10	1.9656113690008278e-07	9	0.02
level0	White matter microstructure (fractional anisotropy)	344506	240	1138	10	1.0842339389541121e-08	1.0419488153349016e-05	4	0.01
level0	Alzheimer's disease (late onset)	344506	123	1138	6	3.921476007868313e-06	0.0037685384435614	1	0.004
level0	Parkinson's disease	344506	374	1138	13	6.353099594089247e-10	6.105328709919767e-07	10	0.022
level0	Alzheimer's disease	344506	342	1138	18	2.8662544597135393e-16	2.754470535784712e-13	5	0.012
level0	Neuroticism	344506	1057	1138	16	7.780248384848734e-07	0.0007476818697839	12	0.026
level0	ACPA-positive rheumatoid arthritis (smoking interaction)	344506	15	1138	5	1.1390927673447767e-09	1.0946681494183304e-06	1	0.004
level0	Epstein Barr virus nuclear antigen 1 IgG levels	344506	6	1138	3	7.13676909925894e-07	0.0006858435104387	3	0.008
level0	Immunoglobulin A vasculitis	344506	60	1138	13	2.3322077705009455e-20	2.241251667451409e-17	6	0.014
level0	Alzheimer's disease or family history of Alzheimer's disease	344506	309	1138	34	2.666901767943476e-40	2.5628925989936804e-37	3	0.008
level0	Family history of Alzheimer's disease	344506	87	1138	12	2.2524830668973885e-16	2.1646362272883905e-13	2	0.006
level0	Response to hepatitis B vaccine	344506	21	1138	3	4.573334006380338e-05	0.043949739801315	6	0.014
level0	Major depressive disorder or stress-related disorder	344506	242	1138	40	1.3882889258866088e-54	1.3341456577770313e-51	8	0.018
level0	Non-lobar intracerebral hemorrhage (MTAG)	344506	42	1138	4	1.1995404800093164e-05	0.0115275840128895	3	0.008
level0	Alzheimer's disease (onset between ages 58 and 79)	344506	28	1138	4	2.2765200214395222e-06	0.0021877357406033	0	0.002
level0	Depressed affect	344506	157	1138	8	6.845231886800838e-08	6.578267843215604e-05	1	0.004
level0	General factor of neuroticism	344506	308	1138	9	1.150286422616443e-06	0.0011054252521344	13	0.028
level0	Extraintestinal manifestations in inflammatory bowel disease (primary sclerosing cholangitis)	344506	10	1138	3	4.239925826615373e-06	0.0040745687193773	1	0.004
level0	Inguinal hernia	344506	2192	1138	45	1.3516240895148549e-21	1.2989107500237756e-18	16	0.034
level0	Ubiquitin carboxyl-terminal hydrolase 25 levels (USP25.9215.117.3)	344506	15	1138	4	1.570507293222927e-07	0.0001509257508787	5	0.012
level0	Succinylcarnitine levels	344506	18	1138	5	3.223372792085362e-09	3.0976612531940328e-06	1	0.004
level0	Aspartylphenylalanine levels	344506	2	1138	2	1.0902106176474466e-05	0.0104769240355919	0	0.002
level0	Alzheimerâ€™s disease polygenic risk score (upper quantile vs lower quantile)	344506	477	1138	13	1.151568271115972e-08	1.106657108542449e-05	0	0.002
level0	Hypothyroidism or rheumatoid arthritis (pleiotropy)	344506	1035	1138	140	2.243902124622415e-176	2.1563899417621406e-173	19	0.04
level0	Seropositivity for staphylococcus aureus subsp. aureus MRSA252 peptide (agilent_24484)	344506	2	1138	2	1.0902106176474466e-05	0.0104769240355919	1	0.004
level0	Seropositivity for streptococcus pneumoniae peptide (agilent_229734)	344506	3	1138	2	3.263441926597593e-05	0.0313616769146028	0	0.002
level0	Seropositivity for human gammaherpesvirus 4 (Epstein-Barr virus) peptide (agilent_1075)	344506	3	1138	2	3.263441926597593e-05	0.0313616769146028	0	0.002
level0	Seropositivity for gallus peptide (twist_24274)	344506	7	1138	3	1.245850044865572e-06	0.0011972618931158	4	0.01
level0	Seropositivity for oryza sativa (rice) peptide (twist_19685)	344506	3	1138	2	3.263441926597593e-05	0.0313616769146028	0	0.002
level0	Seropositivity for human gammaherpesvirus 4 (Epstein-Barr virus) peptide (twist_32108)	344506	3	1138	2	3.263441926597593e-05	0.0313616769146028	0	0.002
level0	Seropositivity for lactobacillus phage LFEINF peptide (twist_64023)	344506	18	1138	3	2.8267430957446337e-05	0.0271650011501059	3	0.008
level0	Seropositivity for human mastadenovirus peptide (agilent_329)	344506	2	1138	2	1.0902106176474466e-05	0.0104769240355919	0	0.002
level0	Seropositivity for mycobacterium tuberculosis peptide (agilent_10341)	344506	2	1138	2	1.0902106176474466e-05	0.0104769240355919	0	0.002
level0	Seropositivity for human twist-related protein 1 peptide (twist_46270)	344506	2	1138	2	1.0902106176474466e-05	0.0104769240355919	0	0.002
level0	Seropositivity for staphylococcus aureus subsp. aureus strain newman peptide (agilent_239239)	344506	3	1138	2	3.263441926597593e-05	0.0313616769146028	1	0.004
level0	Seropositivity for staphylococcus aureus peptide (agilent_222381)	344506	47	1138	4	1.886588483194829e-05	0.0181301153235023	2	0.006
level1	White matter microstructure (radial diusivities)	344506	250	709	6	1.5518033230952633e-05	0.0121506200198359	11	0.024
level1	Hemoglobin concentration	344506	1081	709	11	2.0155833217091795e-05	0.0157820174089828	8	0.018
level1	Household income	344506	70	709	4	1.4641326721208149e-05	0.0114641588227059	1	0.004
level1	Neuroticism	344506	1057	709	13	4.628528503635599e-07	0.0003624137818346	19	0.04
level1	Osteoarthrosis (time to event)	344506	5	709	2	4.21214888761776e-05	0.032981125790047	5	0.012
level1	Parkinson's disease	344506	374	709	18	3.7903748487505937e-19	2.9678635065717153e-16	19	0.04
level1	Corticobasal degeneration	344506	6	709	2	6.30958343147067e-05	0.0494040382684153	4	0.01
level1	Serum galactose-deficient IgA1 levels	344506	4	709	2	2.5307506100653905e-05	0.019815777276812	12	0.026
level1	Immunoglobulin A vasculitis	344506	60	709	6	3.388511968679587e-09	2.6532048714761166e-06	11	0.024
level1	IDP dMRI TBSS MD Anterior limb of internal capsule R	344506	4	709	2	2.5307506100653905e-05	0.019815777276812	6	0.014
level1	IDP dMRI ProbtrackX L1 str r	344506	3	709	2	1.2671086068992134e-05	0.0099214603920208	7	0.016
level1	Serum levels of protein KNG1	344506	6	709	4	2.6594519318531804e-10	2.0823508626410406e-07	14	0.03
level1	Experiencing mood swings	344506	69	709	5	3.6688196948629306e-07	0.0002872685821077	25	0.052
level1	Neurociticism	344506	181	709	5	4.134278123259434e-05	0.0323713977051213	10	0.022
level1	Feeling hurt	344506	46	709	4	2.709931112896497e-06	0.0021218760613979	8	0.018
level1	Feeling worry	344506	71	709	4	1.5490146576872323e-05	0.012128784769691	4	0.01
level1	Irritable mood	344506	67	709	6	6.672442467320974e-09	5.224522451912323e-06	12	0.026
level1	Feeling guilty	344506	29	709	5	4.149709680506698e-09	3.249222679836745e-06	7	0.016
level1	Worry too long after an embarrassing experience	344506	40	709	4	1.5326228233533286e-06	0.0012000436706856	2	0.006
level1	Worry	344506	147	709	5	1.5272706670881177e-05	0.0119585293232999	6	0.014
level1	Reaction time	344506	539	709	10	2.5342888184810125e-07	0.000198434814487	15	0.032
level1	CD27 antigen levels	344506	39	709	5	1.977938334461224e-08	1.5487257158831385e-05	14	0.03
level1	Dual specificity mitogen-activated protein kinase kinase 4 levels	344506	19	709	3	8.206458769481116e-06	0.0064256572165037	14	0.03
level1	Histidine-rich glycoprotein levels	344506	27	709	4	3.006398593985982e-07	0.0002354010099091	14	0.03
level1	Leucine carboxyl methyltransferase 1 levels	344506	4	709	2	2.5307506100653905e-05	0.019815777276812	14	0.03
level1	Kininogen-1 levels	344506	21	709	5	7.208173006471753e-10	5.643999464067384e-07	14	0.03
level1	Asthma and cardiovascular disease	344506	145	709	25	2.758966619250346e-40	2.160270862873021e-37	20	0.042
level1	X-16087 levels	344506	4	709	2	2.5307506100653905e-05	0.019815777276812	5	0.012
level1	3-carboxy-4-methyl-5-pentyl-2-furanpropionate (3-CMPFP) levels	344506	4	709	2	2.5307506100653905e-05	0.019815777276812	5	0.012
level1	X-02269 levels	344506	4	709	2	2.5307506100653905e-05	0.019815777276812	5	0.012
level1	Posterolateral temporal area (unadjusted for global measures)	344506	33	709	3	4.522465540762042e-05	0.0354109051841667	5	0.012
level1	Dorsomedial frontal area (unadjusted for global measures)	344506	54	709	4	5.183635593472684e-06	0.0040587866696891	7	0.016
level1	Occipital area (unadjusted for global measures)	344506	45	709	5	4.154563083947521e-08	3.2530228947309084e-05	7	0.016
level1	Mitochondrial DNA copy number (raw)	344506	141	709	5	1.2489726826092658e-05	0.0097794561048305	0	0.002
level1	Anteromedial temporal area (unadjusted for global measures)	344506	29	709	3	3.047432724653277e-05	0.0238613982340351	6	0.014
level1	Dorsolateral prefrontal area (unadjusted for global measures)	344506	48	709	5	5.7930102423017375e-08	4.53592701972226e-05	9	0.02
level1	COVID-19 severity	344506	47	709	6	7.434619861777587e-10	5.82130735177185e-07	7	0.016
level1	Precuneus area (unadjusted for global measures)	344506	34	709	3	4.952522859260327e-05	0.0387782539880083	6	0.014
level1	Superior parietal area (unadjusted for global measures)	344506	30	709	3	3.3808456658778485e-05	0.0264720215638235	6	0.014
level1	Ventromedial occipital thickness (unadjusted for global measures)	344506	32	709	3	4.117642608042278e-05	0.032241141620971	5	0.012
level1	Breast cancer or critical COVID-19 (pleiotropy)	344506	6	709	3	1.7279789460881533e-07	0.0001353007514787	7	0.016
level1	Ovarian cancer or hospitalized COVID-19 (pleiotropy)	344506	6	709	3	1.7279789460881533e-07	0.0001353007514787	7	0.016
level1	Ovarian cancer or critical COVID-19 (pleiotropy)	344506	4	709	3	3.466604423331459e-08	2.714351263468533e-05	7	0.016
level1	Major depressive disorder or hospitalized COVID-19 (pleiotropy)	344506	6	709	2	6.30958343147067e-05	0.0494040382684153	4	0.01
level1	Myosin regulatory light chain 2, atrial isoform levels	344506	6	709	2	6.30958343147067e-05	0.0494040382684153	14	0.03
level1	Left ventricular end diastole inferoseptal wall thickness	344506	5	709	2	4.21214888761776e-05	0.032981125790047	5	0.012
level1	Hepatitis B virus antibody levels	344506	5	709	2	4.21214888761776e-05	0.032981125790047	11	0.024
level1	Seropositivity for streptococcus pneumoniae peptide (agilent_224401)	344506	14	709	3	3.106484163983497e-06	0.002432377100399	5	0.012
level1	Seropositivity for streptococcus pneumoniae peptide (agilent_241214)	344506	14	709	3	3.106484163983497e-06	0.002432377100399	5	0.012
level1	Seropositivity for streptococcus pyogenes peptide (agilent_235068)	344506	18	709	3	6.921324127851756e-06	0.0054193967921079	9	0.02
level2	Chronic hepatitis B infection	344506	19	797	3	1.1626905860154564e-05	0.0105339767093	9	0.02
level2	Immune response to measles vaccine (measles-specific neutralising antibody titre)	344506	4	797	2	3.1973718216444665e-05	0.0289681887040988	16	0.034
level2	Immunoglobulin A vasculitis	344506	60	797	9	2.4146587577236604e-14	2.1876808344976358e-11	13	0.028
level2	CD4+ CD8dim T cell %lymphocyte	344506	4	797	2	3.1973718216444665e-05	0.0289681887040988	25	0.052
level2	CD8 on Natural Killer T	344506	2	797	2	5.345385971493385e-06	0.004842919690173	1	0.004
level2	Epidermal growth factor levels	344506	4	797	2	3.1973718216444665e-05	0.0289681887040988	13	0.028
level2	CEACAM8/MMP9 protein level ratio	344506	3	797	2	1.60114871946076e-05	0.0145064073983144	4	0.01
level2	CLEC4D/MMP9 protein level ratio	344506	5	797	2	5.3207578688360646e-05	0.0482060662916547	0	0.002
level2	CD46/NECTIN2 protein level ratio	344506	4	797	2	3.1973718216444665e-05	0.0289681887040988	0	0.002
level2	Asthma (childhood onset)	344506	400	797	7	4.86081326743944e-05	0.0440389682030013	0	0.002
level2	Human Chorionic Gonadotropin levels	344506	13	797	3	3.4674338468973143e-06	0.0031414950652889	23	0.048
level2	Luteinizing hormone levels (CGA.LHB.2953.31.2)	344506	2	797	2	5.345385971493385e-06	0.004842919690173	23	0.048
level2	Tyrosine-protein phosphatase non-receptor type substrate 1 levels	344506	30	797	4	7.427043066439449e-07	0.0006728901018194	25	0.052
level2	Luteinizing hormone levels	344506	3	797	3	1.2335362860121794e-08	1.1175838751270346e-05	23	0.048
level2	Programmed cell death 1 ligand 1 levels	344506	15	797	3	5.49734021572347e-06	0.0049805902354454	13	0.028
level2	Tyrosine-protein phosphatase non-receptor type substrate 1 levels (SIRPA.5430.66.3)	344506	2	797	2	5.345385971493385e-06	0.004842919690173	25	0.052
level2	Human Chorionic Gonadotropin levels (CGA.CGB.4914.10.1)	344506	3	797	3	1.2335362860121794e-08	1.1175838751270346e-05	23	0.048
level2	10-undecenoate (11:1n1) levels	344506	10	797	4	5.904684180375786e-09	5.349643867420463e-06	11	0.024
level2	Rheumatoid arthritis or multiple sclerosis	344506	53	797	5	1.7130459199774706e-07	0.0001552019603499	4	0.01
level2	Verbal learning	344506	131	797	12	5.342454746113056e-16	4.840263999978429e-13	33	0.068
level2	Dodecanedioate levels	344506	5	797	2	5.3207578688360646e-05	0.0482060662916547	6	0.014
level2	COVID-19 hospitalization or systemic lupus erythematosus (MTAG)	344506	17	797	3	8.187466580108432e-06	0.0074178447215782	3	0.008
level2	Manganese-transporting ATPase 13A1 levels	344506	4	797	2	3.1973718216444665e-05	0.0289681887040988	17	0.036
level2	Hypothyroidism or rheumatoid arthritis (pleiotropy)	344506	1035	797	50	2.306683339215005e-48	2.0898551053287944e-45	45	0.092
level2	Seropositivity for human gammaherpesvirus 4 (Epstein-Barr virus) peptide (twist_34377)	344506	4	797	2	3.1973718216444665e-05	0.0289681887040988	6	0.014
level2	Seropositivity for human gammaherpesvirus 4 (Epstein-Barr virus) peptide (twist_52109)	344506	5	797	2	5.3207578688360646e-05	0.0482060662916547	5	0.012
level3	Chronic hepatitis B infection	344506	19	957	5	1.8430461621531282e-09	1.7472077617211658e-06	7	0.016
level3	Antineutrophil cytoplasmic antibody-associated vasculitis	344506	30	957	4	1.531028892226168e-06	0.0014514153898304	3	0.008
level3	Inflammatory bowel disease	344506	665	957	10	2.231130543355712e-05	0.0211511175510121	23	0.048
level3	Systemic lupus erythematosus	344506	863	957	12	7.612895155223136e-06	0.0072170246071515	14	0.03
level3	IgA nephropathy	344506	159	957	6	6.430611609900081e-06	0.0060962198061852	1	0.004
level3	Monocyte count	344506	1767	957	16	5.0855843243028965e-05	0.0482113393943914	33	0.068
level3	Hepatitis B	344506	50	957	4	1.231022552169298e-05	0.0116700937945649	0	0.002
level3	Epstein-Barr virus VCA p18 antibody levels	344506	2	957	2	7.708635497592351e-06	0.0073077864517175	2	0.006
level3	Adult asthma	344506	45	957	4	8.052594535842992e-06	0.0076338596199791	4	0.01
level3	Mouth ulcers	344506	94	957	5	7.322920615668797e-06	0.006942128743654	0	0.002
level3	Response to hepatitis B vaccine	344506	21	957	5	3.210506681705254e-09	3.043560334256581e-06	4	0.01
level3	HLA DR++ monocyte %monocyte	344506	3	957	2	2.308316826374443e-05	0.0218828435140297	1	0.004
level3	SSC-A on CD14+ monocyte	344506	4	957	2	4.6081037581521e-05	0.0436848236272819	3	0.008
level3	CD40LG/LYN protein level ratio	344506	4	957	2	4.6081037581521e-05	0.0436848236272819	0	0.002
level3	Neutralising antibody response to interferon beta therapy in multiple sclerosis (antibody titre; IFNÎ²-1b subcutaneous)	344506	2	957	2	7.708635497592351e-06	0.0073077864517175	3	0.008
level3	Neutralising antibody response to interferon beta therapy in multiple sclerosis (presence of antibodies; IFNÎ²-1b subcutaneous)	344506	2	957	2	7.708635497592351e-06	0.0073077864517175	3	0.008
level3	Lysozyme C levels	344506	6	957	3	4.247253665358598e-07	0.0004026396474759	38	0.078
level3	Lysozyme C levels (LYZ.4920.10.1)	344506	2	957	2	7.708635497592351e-06	0.0073077864517175	36	0.074
level3	Crohn's disease vs rheumatoid arthritis (ordinary least squares (OLS))	344506	24	957	3	4.140584413243824e-05	0.0392527402375514	0	0.002
level3	Idiopathic achalasia	344506	4	957	2	4.6081037581521e-05	0.0436848236272819	0	0.002
level3	Orotate levels	344506	11	957	4	1.9227484941200362e-08	1.822765572425794e-05	25	0.052
level3	Behenoylcarnitine (C22) levels	344506	4	957	2	4.6081037581521e-05	0.0436848236272819	2	0.006
level3	Uridine levels	344506	12	957	3	4.614104235231263e-06	0.0043741708149992	40	0.082
level3	Resistance to COVID-19 infection (Exposed negative vs positive)	344506	522	957	9	1.982478728533393e-05	0.0187938983464965	52	0.106
level3	Hypothyroidism or rheumatoid arthritis (pleiotropy)	344506	1035	957	12	4.4417245330880846e-05	0.042107548573675	71	0.144
level3	Steroid-dependent/frequent relapse nephrotic syndrome	344506	11	957	3	3.467772537020387e-06	0.0032874483650953	10	0.022
level3	Seropositivity for streptococcus phage peptide (twist_76831)	344506	3	957	2	2.308316826374443e-05	0.0218828435140297	1	0.004
level3	Seropositivity for lactobacillus phage LFEINF peptide (twist_64023)	344506	18	957	3	1.6902301785902378e-05	0.0160233820930354	3	0.008
level3	Seropositivity (peptide co-occurrence module 13: ABC transporters , ATP-binding proteins)	344506	4	957	2	4.6081037581521e-05	0.0436848236272819	3	0.008
level4	White matter microstructure (axial diusivities)	344506	160	1464	12	7.176547384133229e-12	1.1116471898022372e-08	66	0.134
level4	Chronic hepatitis B infection	344506	19	1464	5	1.5233058100623405e-08	2.359600699786565e-05	47	0.096
level4	Hip circumference adjusted for BMI	344506	3359	1464	38	1.0728048685417005e-07	0.0001661774741371	51	0.104
level4	Smoking cessation	344506	320	1464	9	1.1759989253065686e-05	0.0182162233529987	40	0.082
level4	Waist-to-hip ratio adjusted for BMI	344506	3741	1464	41	7.92704835755376e-08	0.0001227899790585	65	0.132
level4	IgG glycosylation patterns	344506	56	1464	7	4.772448485333512e-09	7.39252270378161e-06	74	0.15
level4	A body shape index	344506	1514	1464	27	9.756021001700723e-10	1.5112076531634424e-06	39	0.08
level4	Waist-hip index	344506	2526	1464	34	8.830627927536848e-09	1.3678642659754576e-05	48	0.098
level4	Imidazole lactate levels	344506	28	1464	5	1.247248349627191e-07	0.0001931987693572	65	0.132
level4	Eczema	344506	249	1464	9	1.5552369180630998e-06	0.0024090619860797	10	0.022
level4	Eye color	344506	135	1464	7	2.128609523064957e-06	0.0032972161512276	19	0.04
level4	Extraintestinal manifestations in inflammatory bowel disease (primary sclerosing cholangitis)	344506	10	1464	3	8.98770323695016e-06	0.0139219523140357	1	0.004
level4	Phosphatidylcholine-O_44:5_[M+OAc]1-/Phosphatidylcholine-P_44:4_[M+OAc]1- levels	344506	28	1464	4	6.130360479398743e-06	0.0094959283825886	81	0.164
level4	Killer cell immunoglobulin-like receptor 2DS2 levels (KIR2DS2.10428.1.3)	344506	6	1464	4	4.838881544206579e-09	7.495427511975991e-06	48	0.098
level4	Phoneme awareness	344506	75	1464	5	1.856442001174489e-05	0.0287562865981928	22	0.046
level4	X-17357 levels	344506	14	1464	3	2.691811279543649e-05	0.0416961567201311	0	0.002
level4	X-18886 levels	344506	5	1464	3	7.609907563736931e-07	0.0011787746816228	25	0.052
level4	Opioid use disorder	344506	19	1464	4	1.1964232223735325e-06	0.0018532595714566	21	0.044
level4	X-23639 levels	344506	10	1464	3	8.98770323695016e-06	0.0139219523140357	7	0.016
